The adoption of value-based care and shared-risk arrangements among hospitals, health systems, and health plans is documented in a 2024 survey conducted by the Health Care Payment Learning and Action Network. Nearly 40% of commercial payment dollars flowed through shared-savings, shared-risk or population-based payment models in 2023.
Under these value-based agreements, health insurers link provider payment to care quality and, in some arrangements, spending. In contracts that share savings and losses, the insurer particularly needs to anticipate members' care needs and the costs of meeting them.
Anticipating these changes becomes harder when finance, care management and provider partners work from different information. Finance may estimate spending from past claims, while care management may have newer information about disease progression or treatment response. Without a shared understanding of the care members may need, the insurer's financial assumptions and the provider's plans for delivering care can fall out of step with members' needs.
Precision world models can give these teams a shared forecast of possible treatment changes or complications, their likelihood and timing. Care management can assess the provider's plans for meeting those needs while finance estimates the costs, helping the parties plan care around members' expected needs. That shared picture gives the insurer a clinical basis for negotiating how care will be funded and financial risk divided.
What a Shared World Model Explains
A healthcare world model uses artificial intelligence to represent a member's current condition, the factors associated with change, and possible care paths over time. An evidence-grounded design combines clinical evidence with member records to estimate the likelihood and timing of treatment changes or complications. Sharing the model means finance, care management, and provider partners use the same clinical estimates, underlying information, and forecast period. This complements large language models (LLMs), which provide contextual access to evidence, by modeling the patient-specific clinical dynamics behind anticipated care needs.
For a member whose treatment is no longer controlling an illness, the model may identify an increased likelihood of another therapy and connect that estimate to treatment response and other clinical information, giving care management a basis for reviewing the anticipated change with the treating team. The forecast supports preparation for that possible transition while treatment decisions remain with treating professionals.
Here, precision means specificity to the member and condition/diagnosis, not certainty about future care. Inspecting the records, medical sources and uncertain assumptions behind an estimate helps reviewers judge how much confidence to place in them.
Evidence for this approach includes a retrospective surgical study, published in September 2026, which found that a world model distinguished patients who developed complications from those who did not, more effectively than the tested models based on a single health assessment. The finding supports the predictive approach, but it doesn't establish improved outcomes or savings from using it in insurance.
For insurance contracts, that predictive approach also requires evidence that a model's probabilities are reliable for the covered population. Testing on data that reflects that population and wasn't used to develop the model helps establish whether events occur as often as predicted. Overstating the likelihood of expensive treatment can distort financial planning even when a model correctly identifies the highest-risk members.
Translating Expected Care Into Contract Decisions
With those clinical estimates available to both teams and other stakeholders, finance can apply contracted prices to anticipated services, accounting for their likelihood. Care management can compare the expected needs with the provider's appointments, staffing and follow-up processes. Together, these assessments connect projected spending with the capacity to deliver care.
At the population level, two provider groups could have similar expected spending but different exposure to expensive events, with one including several members likely to change treatments and another facing a small chance of an exceptionally costly complication. The average alone cannot show how often losses might occur or how large they could be. Those differences inform the discussion of how much financial risk each party would bear, alongside actuarial, operational and other considerations.
Risk corridors can specify how savings or losses are shared across spending ranges, while quality bonuses can reward agreed measures of care performance. Understanding the clinical events behind projected costs helps the parties examine whether those terms support appropriate care and assign financial responsibility the provider can reasonably manage. A necessary treatment change can raise spending, so higher costs alone don't establish a failure of care management.
The provider's ability to meet these needs also depends on when funding becomes available, since additional clinical staff or coordination services may be needed before savings or bonuses are paid. The expected care path gives negotiators a basis for deciding who funds that work and when, allowing care management to assess whether the proposed funding supports the services anticipated in the model.
Estimating the insurer's own exposure also means distinguishing its payments from the contract's spending measure, which may include member cost sharing. Finance accounts for any additional amounts owed or received under the agreement when calculating the insurer's net cost.
Use the Shared Picture Throughout the Agreement
The assumptions used to negotiate the contract provide a reference once it begins. Keeping the model version, information cutoff date, and original estimates preserves what both teams knew when the terms were set. Comparing anticipated care with services delivered then identifies differences for review, while payment records show what the care cost.
New clinical information can update expectations for the remaining period as treatment change becomes more likely, prompting the insurer and provider to review whether scheduled services and funding still match the member's needs. If that review reveals a missing specialist appointment, the parties have a specific coordination problem to resolve before treatment begins.
Those records help investigate why results differed from expectations, while judgments about preventability or provider responsibility require clinical review and evidence of the care delivered. Establishing whether an intervention improved outcomes or reduced spending requires an appropriate comparison.
Actual spending, measured quality and the contract's rules determine the financial settlement. The next contract discussion should begin with a shared explanation of members' care needs and how to meet them, using the record to distinguish changes in those needs from delivery gaps and justify revisions to risk assumptions, funding, or how gains and losses are shared.
